|
Can diet and exercise improve response to
immunotherapy? It's a common question we receive from patients, caregivers,
and advocates, but it's difficult to provide strong, science-based answers.
A new study may change that with your help.
The National Cancer Institute (NCI) is conducting
a new clinical trial called "EDEN,"
investigating the link between diet, exercise, and changes in the gut
microbiome that may improve response to immunotherapy. They are currently
recruiting adult patients with unresectable melanoma who are/will be
treated with an immune checkpoint inhibitors—pembrolizumab (Keytruda) and
nivolumab (Opdivo)—in a first-line setting.
- All
appointments are conducted via telehealth so patients can enroll from
anywhere in the United States and there is no need to travel.
- No changes
will be made to the treatment plan. The study investigators will work
with local oncologists.
- Participants
will receive a free activity tracker and digital scale to report on
progress.
Watch
a short video about the EDEN study to learn more about its design and
goals. We're excited to work with the NCI and share this study with you
because it addresses an important question for both researchers and
patients in a smart and approachable way.
We encourage you to share this study with your
cancer community. Potential participants should contact the NCI directly at
NCIEDENstudy@mail.nih.gov or
+1-240-858-3525.
Thank you,
Brian Brewer
Chief Communications Officer
Cancer Research Institute
|
No comments:
Post a Comment